Loading stock data…
MED
$10.91+0.04 (+0.37%)
Market ClosedLast close May 1
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Medifast, Inc. in the Consumer Cyclical sector is trading at $10.91. The stock is currently 29% below its 52-week high of $15.46, remaining 8.9% below its 200-day moving average. Technical signals show neutral RSI of 59 and bullish MACD crossover, explaining why MED maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 59) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
AMZNTSLAHD
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.91
Potential Upside
5%
Whystock Fair Value$11.46
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and hea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$121.13M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.56
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.83%
Volume
Today's trading volume
89,703
Recent News
3 Unprofitable Stocks Walking a Fine Line
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Medifast's New Product Pipeline: Key Catalyst for Comeback?
MED's science-led metabolic health push and new product pipeline could spark a turnaround as it targets GLP-1 transition users and profitability growth.
3 Consumer Stocks That Concern Us
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over the past six months as it tumbled 5.5%. This drawdown was worse than the S&P 500’s 2.3% loss.
Hims & Hers Advances a Consumer-Centric Digital Health Platform
HIMS is broadening its digital-first platform with Labs, hormone therapy and weight-loss programs as it scales personalized care globally.
We Think MEDICLIN's (ETR:MED) Solid Earnings Are Understated
MEDICLIN Aktiengesellschaft's ( ETR:MED ) recent earnings report didn't offer any surprises, with the shares unchanged...